Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MEDICARE COVERAGE OF INVESTIGATIONAL DEVICES SUPPORTED BY "INCREMENTAL NATURE" OF DEVELOPMENT, HIMA TESTIFIES; HCFA TO ISSUE POLICY ON OFF-LABEL PAYMENT

This article was originally published in The Gray Sheet

Executive Summary

The "incremental nature" of device development argues for Medicare coverage of investigational devices, Thomas Long, vice president of payment and policy at the Health Industry Manufacturers Association asserted at a Sept. 12 meeting of the Health Care Financing Administration's Practicing Physicians Advisory Council.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002821

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel